Literature DB >> 17913706

Myc down-regulation as a mechanism to activate the Rb pathway in STAT5A-induced senescence.

Frédérick A Mallette1, Marie-France Gaumont-Leclerc, Geneviève Huot, Gerardo Ferbeyre.   

Abstract

Senescence is a general antiproliferative program that avoids the expansion of cells bearing oncogenic mutations. We found that constitutively active STAT5A (ca-STAT5A) can induce a p53- and Rb-dependent cellular senescence response. However, ca-STAT5A did not induce p21 and p16(INK4a), which are responsible for inhibiting cyclin-dependent protein kinases and engaging the Rb pathway during the senescence response to oncogenic ras. Intriguingly, ca-STAT5A led to a down-regulation of Myc and Myc targets, including CDK4, a negative regulator of Rb. The down-regulation of Myc was in part proteasome-dependent and correlated with its localization to promyelocytic leukemia bodies, which were found to be highly abundant during STAT5-induced senescence. Introduction of CDK4 or Myc bypassed STAT5A-induced senescence in cells in which p53 was also inactivated. These results uncover a novel mechanism to engage the Rb pathway in oncogene-induced senescence and indicate the existence of oncogene-specific pathways that regulate senescence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17913706     DOI: 10.1074/jbc.M707074200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Methods to Study Myc-Regulated Cellular Senescence: An Update.

Authors:  Fan Zhang; Wesam Bazzar; Mohammad Alzrigat; Lars-Gunnar Larsson
Journal:  Methods Mol Biol       Date:  2021

2.  Cellular senescence and protein degradation: breaking down cancer.

Authors:  Xavier Deschênes-Simard; Frédéric Lessard; Marie-France Gaumont-Leclerc; Nabeel Bardeesy; Gerardo Ferbeyre
Journal:  Cell Cycle       Date:  2014-05-27       Impact factor: 4.534

3.  Interleukin 6 signaling regulates promyelocytic leukemia protein gene expression in human normal and cancer cells.

Authors:  Sona Hubackova; Katerina Krejcikova; Jiri Bartek; Zdenek Hodny
Journal:  J Biol Chem       Date:  2012-06-18       Impact factor: 5.157

4.  Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPARγ-independent mechanism.

Authors:  Tunde O Akinyeke; LaMonica V Stewart
Journal:  Cancer Biol Ther       Date:  2011-06-15       Impact factor: 4.742

5.  SOCS1, a novel interaction partner of p53 controlling oncogene-induced senescence.

Authors:  Frédérick A Mallette; Viviane Calabrese; Subburaj Ilangumaran; Gerardo Ferbeyre
Journal:  Aging (Albany NY)       Date:  2010-07       Impact factor: 5.682

Review 6.  The different functions of Stat5 and chromatin alteration through Stat5 proteins.

Authors:  Jan-Wilhelm Kornfeld; Florian Grebien; Marc A Kerenyi; Katrin Friedbichler; Boris Kovacic; Barbara Zankl; Andrea Hoelbl; Harini Nivarti; Hartmut Beug; Veronika Sexl; Mathias Muller; Lukas Kenner; Ernst W Mullner; Fabrice Gouilleux; Richard Moriggl
Journal:  Front Biosci       Date:  2008-05-01

7.  Preliminary study on XAGE-1b gene and its mechanism for promoting tumor cell growth.

Authors:  Bo Zhou; Tingxiu Li; Yang Liu; Naishuo Zhu
Journal:  Biomed Rep       Date:  2013-05-30

8.  Mitochondrial dysfunction contributes to oncogene-induced senescence.

Authors:  Olga Moiseeva; Véronique Bourdeau; Antoine Roux; Xavier Deschênes-Simard; Gerardo Ferbeyre
Journal:  Mol Cell Biol       Date:  2009-06-15       Impact factor: 4.272

9.  Angiogenic properties of aged adipose derived mesenchymal stem cells after hypoxic conditioning.

Authors:  Anastasia Efimenko; Ekaterina Starostina; Natalia Kalinina; Alexandra Stolzing
Journal:  J Transl Med       Date:  2011-01-18       Impact factor: 5.531

Review 10.  Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer development.

Authors:  Kristina M Mueller; Madeleine Themanns; Katrin Friedbichler; Jan-Wilhelm Kornfeld; Harald Esterbauer; Jan P Tuckermann; Richard Moriggl
Journal:  Mol Cell Endocrinol       Date:  2012-04-30       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.